Most recently, InSilico Medicine Cayman (HKG: 03696) raised $13.0M in its Series E extension (final close) (Jun 2025).
- ·The complete investor list: 50 names
- ·Watch InSilico Medicine Cayman (HKG: 03696): the Monday email on marks, rounds and moves
InSilico Medicine Cayman (HKG: 03696) round by round
6 roundsHow much has InSilico Medicine Cayman (HKG: 03696) raised?
InSilico Medicine Cayman (HKG: 03696) has raised $842 million across 6 recorded rounds since 2019. The largest was a $60 million Series D in Jun 2022; the most recent was a $13 million Series E extension (final close) in Jun 2025.
InSilico Medicine Cayman (HKG: 03696) investors
50 investors are on record for InSilico Medicine Cayman (HKG: 03696), including Hongshan Capital Group, F-Prime Capital, Qiming Venture Partners and Eight Roads. By type, the record holds 9 venture capital firms and 3 asset managers.
50 investors have backed InSilico Medicine Cayman (HKG: 03696) — start your target list with the firms already writing checks in biotech.
Frequently asked about InSilico Medicine Cayman (HKG: 03696)
- How much has InSilico Medicine Cayman (HKG: 03696) raised?
- InSilico Medicine Cayman (HKG: 03696) has raised $841.9M in total across 6 recorded funding rounds.
- When was InSilico Medicine Cayman (HKG: 03696)'s last funding round?
- InSilico Medicine Cayman (HKG: 03696)'s most recent recorded round was Series E extension (final close) in Jun 2025, raising $13.0M.